{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:49:32Z","timestamp":1792234172717,"version":"4.4.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To characterize current trends and outcomes in pregnancies complicated by cystic fibrosis (CF) that resulted in delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This repeated cross-sectional study used the U.S. National Inpatient Sample to identify delivery hospitalizations of patients with CF between 2000 and 2019. Trends in delivery hospitalizations of patients with CF were assessed using joinpoint regression to determine the average annual percent change (AAPC). The risk of adverse maternal and obstetric outcomes was compared between patients with and without CF using adjusted logistic regression models accounting for demographic, clinical, and hospital characteristics, with adjusted odds ratios (aORs) with 95% CIs as measures of association. The proportion of patients with CF and other chronic conditions such as pregestational diabetes was analyzed over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>From 2000 to 2019, the prevalence of CF at delivery increased from 2.1 to 10.4 per 100,000 deliveries (AAPC 6.7%, 95% CI 5.7\u20138.2%). The proportion of patients with CF and other chronic conditions increased from 18.0% to 37.3% (AAPC 3.1%, 95% CI 1.0\u20135.3%). Patients with CF were more likely to experience severe maternal morbidity (aOR 2.61, 95% CI 1.71\u20133.97), respiratory complications (aOR 17.45, 95% CI 11.85\u201325.68), venous thromboembolism (aOR 3.59, 95% CI 1.33\u20139.69), preterm delivery (aOR 2.15, 95% CI 1.79\u20132.59), abruption and antepartum hemorrhage (aOR 1.63, 95% CI 1.10\u20132.41), and gestational diabetes (aOR 2.47, 95% CI 2.47\u20133.70).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Although still infrequent (approximately 1 in 10,000), deliveries complicated by CF increased approximately fivefold over the study period. The proportion of patients with CF and other chronic conditions is increasing. Patients with CF are at increased risk for a broad range of adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004959","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T17:03:15Z","timestamp":1665075795000},"page":"861-868","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Trends in and Outcomes of Deliveries Complicated by Cystic Fibrosis"],"prefix":"10.1097","volume":"140","author":[{"given":"Christina N.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"DiMango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice H.","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim C.","family":"Sobhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"D'Alton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI6222","article-title":"The genesis of cystic fibrosis lung disease","volume":"103","author":"Wine","year":"1999","journal-title":"J Clin Invest"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.chest.2021.07.024","article-title":"Fertility and pregnancy in cystic fibrosis","volume":"160","author":"Shteinberg","year":"2021","journal-title":"Chest"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1753495X14554022","article-title":"Pregnancy and cystic fibrosis: approach to contemporary management","volume":"7","author":"Geake","year":"2014","journal-title":"Obstet Med"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2020.09.002","article-title":"Baseline cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression","volume":"20","author":"Cohen-Cymberknoh","year":"2021","journal-title":"J Cyst Fibros"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajog.2018.08.044","article-title":"Historical (retrospective) cohort studies and other epidemiologic study designs in perinatal research","volume":"219","author":"Klebanoff","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10995-007-0256-6","article-title":"An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity","volume":"12","author":"Kuklina","year":"2008","journal-title":"Matern Child Health J"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/AOG.0000000000004099","article-title":"Identification of delivery encounters using International Classification of Diseases, Tenth Revision, diagnosis and procedure codes","volume":"136","author":"Clapp","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"98.e1","DOI":"10.1016\/j.ajog.2014.07.018","article-title":"Medical and obstetric complications among pregnant women with cystic fibrosis","volume":"212","author":"Patel","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20260916","first-page":"700","article-title":"Interpreting estimates of treatment effects: implications for managed care","volume":"33","author":"Faraone","year":"2008","journal-title":"P T"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size\u2014or why the P value is not enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J Grad Med Educ"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"e02515","DOI":"10.1016\/j.heliyon.2019.e02515","article-title":"The utility of joinpoint regression for estimating population parameters given changes in population structure","volume":"5","author":"Gillis","year":"2019","journal-title":"Heliyon"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"643.e1","DOI":"10.1016\/j.ajog.2015.11.004","article-title":"Measuring severe maternal morbidity: validation of potential measures","volume":"214","author":"Main","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.contraception.2019.05.005","article-title":"Fertility considerations and attitudes about family planning among women with cystic fibrosis","volume":"100","author":"Traxler","year":"2019","journal-title":"Contraception"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"1901208","DOI":"10.1183\/13993003.01208-2019","article-title":"ERS\/TSANZ Task Force statement on the management of reproduction and pregnancy in women with airways diseases","volume":"55","author":"Middleton","year":"2020","journal-title":"Eur Respir J"},{"issue":"suppl 1)","key":"R29-20260916","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jcf.2007.10.001","article-title":"Guidelines for the management of pregnancy in women with cystic fibrosis","volume":"7(","author":"Edenborough","year":"2008","journal-title":"J Cyst Fibros"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-6215-9-4","article-title":"Improving the outcomes of primary care attenders with common mental disorders in developing countries: a cluster randomized controlled trial of a collaborative stepped care intervention in Goa, India","volume":"9","author":"Patel","year":"2008","journal-title":"Trials"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fped.2018.00142","article-title":"The role of inflammation in venous thromboembolism","volume":"6","author":"Branchford","year":"2018","journal-title":"Front Pediatr"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2021.07.007","article-title":"Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis","volume":"206","author":"Holsteen","year":"2021","journal-title":"Thromb Res"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/14767058.2016.1161747","article-title":"Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis","volume":"30","author":"Jelin","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R34-20260916","first-page":"100289","article-title":"Gestational and pregestational diabetes in pregnant women with cystic fibrosis","volume":"27","author":"Oxman","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/1471-0528.16423","article-title":"The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study","volume":"127","author":"Ashcroft","year":"2020","journal-title":"BJOG"},{"key":"R36-20260916","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2019.06.003","article-title":"Pregnancy outcome in women with cystic fibrosis and poor pulmonary function","volume":"19","author":"Reynaud","year":"2020","journal-title":"J Cyst Fibros"},{"key":"R37-20260916","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/1471-0528.12040","article-title":"The outcome of pregnancies in women with cystic fibrosis\u2014single centre experience 1998\u20132011","volume":"120","author":"Thorpe-Beeston","year":"2013","journal-title":"BJOG"},{"key":"R38-20260916","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/pubmed\/fdr054","article-title":"Systematic review of discharge coding accuracy","volume":"34","author":"Burns","year":"2012","journal-title":"J Public Health (Oxf)"},{"key":"R39-20260916","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/AOG.0b013e31826d7eca","article-title":"Effect of maternal cystic fibrosis genotype on diabetes in pregnancy","volume":"120","author":"Giacobbe","year":"2012","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:01:14Z","timestamp":1789556474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004959","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"2022-06-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}